Cairo – Mubasher: The board of directors of October Pharma assented to increase the firm’s capital by EGP 60 million.

The company’s issued, paid-up, and authorised capital will be increased to EGP 120 million from EGP 60 million, the company said in a filing to the Egyptian Exchange (EGX) on Monday.

It is worth pinpointing that during the first half of 2019, October Pharma’s profits shrank to EGP 3.33 million from EGP 9.99 million during H1-18.

The company’s sales hiked to EGP 239 million during H1-19 from EGP 178 million in the year-ago period.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.